Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 6, 2009, Pages

  Schneider, R ^b   Meusel, M ^b   Renker, S ^b   Bauer, C ^b   Holzinger, H ^a   Roeder, M ^b   Wanner, C ^a   Gekle, M ^c   Sauvant, C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Glomerular filtration rate; Ischemia; Ischemic acute kidney injury; Kidney cortex; Monocytes macrophages; Proximal tubule; Renal plasma flow; Reperfusion

Indexed keywords

4 AMINOHIPPURIC ACID; INDOMETACIN; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

4 AMINOHIPPURIC ACID CLEARANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PLASMA FLOW; LOW DRUG DOSE; MACROPHAGE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RENAL ARTERY; RENAL PROTECTION; REPERFUSION; TREATMENT OUTCOME; URINARY EXCRETION; WESTERN BLOTTING;

EID: 71449084765     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00268.2009     Document Type: Article

References (41)

1. Araujo M, Welch WJ. Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide. Am J Physiol Renal Physiol 296: F790-F794, 2009.
2. Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease? Kidney Int 66: 480-485, 2004.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Buist SC, Cherrington NJ, Klaassen CD. Endocrine regulation of rat organic anion transporters. Drug Metab Dispos 31: 559-564, 2003. (Pubitemid 36444164)
5. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD. PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol Renal Physiol 277: F312-F318, 1999. (Pubitemid 29415151)
6. Cox PG, van Os CH, Russel FG. Accumulation of salicylic acid and indomethacin in isolated proximal tubular cells of the rat kidney. Pharmacol Res 27: 241-252, 1993.
7. Dantzler WH. Renal organic anion transport: a comparative and cellular perspective. Biochim Biophys Acta 1566: 169-181, 2002.
8. Dantzler WH, Wright SH. The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta 1618: 185-193, 2003.
9. Di Giusto G, Anzai N, Endou H, Torres AM. Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology 81: 127-136, 2008. (Pubitemid 351182687)
10. El-Sheikh AA, Masereeuw R, Russel FG. Mechanisms of renal anionic drug transport. Eur J Pharmacol 585: 245-255, 2008.
11. Feitoza CQ, Camara NOS, Pinheiro HS, Goncalves GM, Cenedeze MA, Pacheco-Silva A, Santos OFP. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. International Immunopharmacology 5: 79-84, 2005. (Pubitemid 39626687)
12. Feitoza CQ, Sanders H, Cenedeze M, Camara NOS, Pacheco-Silva A. Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury. Transplant Proc 34: 2979-2980, 2002. (Pubitemid 35304985)
13. Friis C. Renal transport and metabolism of xenobiotics. Actavetscand 32: 33-43, 1991.
14. Habu Y, Yano I, Okuda M, Fukatsu A, Inui Ki. Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney. Biochem Pharmacol 69: 993-999, 2005. (Pubitemid 40312716)
15. Habu Y, Yano I, Takeuchi A, Saito H, Okuda M, Fukatsu A, Inui Ki. Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2. Biochem Pharmacol 66: 1107-1114, 2003. (Pubitemid 37083607)
16. Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 71: 1105-1115, 2007.
17. Hocherl K, Schmidt C, Bucher M. COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex. Kidney Int 75: 373-380, 2009.
18. Kim SJ, Lim YT, Kim BS, Cho SI, Woo JS, Jung JS, Kim YK. Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Ren Fail 22: 129-141, 2000. (Pubitemid 30243979)
19. Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther 301: 293-298, 2002. (Pubitemid 34250307)
20. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-e107, 2008.
21. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274: 13675-13680, 1999. (Pubitemid 129518587)
22. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, Sabolic I. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287: F124-F138, 2004. (Pubitemid 38780592)
23. Matsuzaki T, Watanabe H, Yoshitome K, Morisaki T, Hamada A, Nonoguchi H, Kohda Y, Tomita K, Inui K, Saito H. Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced qacute renal failure. Kidney Int 71: 539-547, 2007. (Pubitemid 46398686)
24. Myers SI, Wang L, Liu F, Bartula LL. Suprarenal aortic clamping and reperfusion decreases medullary and cortical blood flow by decreased endogenous renal nitric oxide and PGE2 synthesis. J Vasc Surg 42: 524-531, 2005. (Pubitemid 41323846)
25. Perri D, Ito S, Rowsell V, Shear NH. The kidney-the body's playground for drugs: an overview of renal drug handling with selected clinical correlates. Can J Clin Pharmacol 10: 17-23, 2003. (Pubitemid 36604474)
26. Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, Freund R, Schramm L, Wanner C, Galle J. L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats. Nephron Physiol 101: p39-p50, 2005. (Pubitemid 41540699)
27. Reyes JL, Melendez E, Alegria A, Jaramillo-Juarez F. Influence of sex differences on the renal secretion of organic anions. Endocrinology 139: 1581-1587, 1998. (Pubitemid 28513812)
28. Russ AL, Haberstroh KM, Rundell AE. Experimental strategies to improve in vitro models of renal ischemia. Exp Mol Pathol 83: 143-159, 2007.
29. Sauvant C, Holzinger H, Gekle M. Prostaglandin E2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3. J Am Soc Nephrol 17: 46-53, 2006.
30. Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambaryan S, Wanner C, Schmidt HHHW, Galle J. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 64: 216-225, 2003. (Pubitemid 36714174)
31. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of paraaminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605, 2007. (Pubitemid 46701888)
32. Sekine T, Miyazaki H, Endou H. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: F251-F261, 2006. (Pubitemid 43724979)
33. Sweet DH, Chan LM, Walden R, Yang XP, Miller DS, Pritchard JB. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. Am J Physiol Renal Physiol 284: F763-F769, 2003. (Pubitemid 36336983)
34. Terlouw SA, Masereeuw R, Russel FG. Modulatory effects of hormones, drugs, and toxic events on renal organic anion transport. Biochem Pharmacol 65: 1393-1405, 2003. (Pubitemid 36555827)
35. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Ozawa Y, Saruta T. Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. Am J Physiol Renal Physiol 282: F859-F865, 2002. (Pubitemid 34654492)
36. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Ozawa Y, Saruta T. Role of nitric oxide and prostaglandin E2 in acute renal hypoperfusion. Nephrology (Carlton) 8: 65-71, 2003. (Pubitemid 36535247)
37. Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. Drug uptake systems in liver and kidney. Curr Drug Metab 4: 185-211, 2003. (Pubitemid 36656478)
38. Villanueva S, Cespedes C, Gonzalez AA, Vio CP, Velarde V. Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney. Am J Physiol Renal Physiol 292: F1364-F1371, 2007. (Pubitemid 46701862)
39. Villar SR, Brandoni A, Anzai N, Endou H, Torres AM. Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int 68: 2704-2713, 2005. (Pubitemid 43251015)
40. Vos IH, Govers R, Grone HJ, Kleij L, Schurink M, De Weger RA, Goldschmeding R, Rabelink TJ. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 14: 815-822, 2000. (Pubitemid 30198580)
41. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987-1049, 2004. (Pubitemid 38823772)